AdvanDx, Inc. Elects Former Roche Molecular Systems, Inc. CEO, Heiner Dreismann, Ph.D., to Its Board of Directors

Published: Mar 27, 2013

BOSTON--(BUSINESS WIRE)--AdvanDx, Inc. announced today that Heiner Dreismann, Ph.D., has joined its board of directors as an independent director. “We are extremely pleased to welcome Heiner as the newest member of the AdvanDx board of directors,” said Dennis H. Langer, M.D., J.D., Chairman and Chief Executive Officer of AdvanDx. “Heiner brings an valuable industry perspective as a director – he has both the breadth of experience throughout the diagnostics industry that will help us expand our core business, as well as a deep understanding of how to develop and commercialize novel molecular diagnostics products for infectious diseases, where our business is focused today. This expertise will provide us with unique insights that will assist us in executing on our mission to develop market-leading, next-generation molecular diagnostic products that make a difference for our customers and their patients, both in the United States and internationally.”

Back to news